An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Clinical trial NCT05426733 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05426733
- Sponsor
- Albireo, an Ipsen Company
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2028-06-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.